Michael Skynner
Vermögen: 649 116 $ am 31.08.2026
Vermögen: 649 116 $ am 31.08.2026
Michael Skynner is the founder of Cambridge Biotechnology Ltd., founded in 2001.
Current jobs include Chief Scientific Officer at Bicycle Therapeutics Plc since 2026 and Chief Operating Officer at Bicycle Therapeutics, Inc. since 2018, both positions starting in 2016.
Former job includes Head-Rare Disease Alliances at Pfizer Inc. from 2013 to 2016.
Education includes a doctorate from Imperial College London.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.07.2026 | 157.171 ( 0,41 % ) | 649 116 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 03.01.2022 |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines and therapeutics for cancer treatment | Geschäftsführer | 01.01.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01.01.2016 |
Cambridge Biotechnology Ltd.
Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops drugs | Gründer | 01.05.2005 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Biotechnology Ltd.
Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops drugs | Commercial Services |
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines and therapeutics for cancer treatment | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen